Orally Disintegrating Tablets (ODTs) are getting increasingly interesting delivery systems in the Pharmaceutical and Nutraceutical fields.
They are an innovative way to handle the product lifecycle management, generate market
differentiation, and increase the interest of consumers.
This webinar will provide you important information to overcome the main challenges during the development of your ODT product.
We will guide you toward a rational way for the selection of the right formulation.
We will focus on the oral disintegration time and on the effect of the excipients on the ODT’s stability.
Elham BLOUET - Moderator
Pharma & Health Market Unit Manager
Javier Andres CAMARGO
Pharmaceutical Project Manager
Case study: KLEPTOSE® BIOPHARMA as a potential functional alternative to surfactants within biologic formulationsKLEPTOSE® BioPharma (hydroxypropyl beta cyclodextrin) represents a promising alternative to surfactants commonly used within biologic formulations, such as polysorbates.
Discover our process to support our commitment towards China DMF Support
A multi-compendial excipient for efficient drug delivery